KRYZA David

Fonction : Maitre de conférence

Spécialité :

Génie Pharmaceutique

Bureau : Rock

Téléphone : 04 78 78 29 06

EMail

47 documents

  • Ilaria Andreana, Mathieu Repellin, Flavia Carton, David Kryza, Stéphanie Briançon, et al.. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics, 2021, 13 (2), pp.278. ⟨10.3390/pharmaceutics13020278⟩. ⟨hal-04112084⟩
  • Ilaria Andreana, Mathieu Repellin, Flavia Carton, David Kryza, Stephanie Briancon, et al.. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics, 2021, 13 (2), pp.278. ⟨10.3390/pharmaceutics13020278⟩. ⟨hal-03151769⟩
  • Aurélie Moreau, Thierry Cruel, Anne Laure Giraudet, Philippe Derolland, David Kryza. Incidental Finding of Hibernoma in Prostate-Specific Membrane Antigen PET/CT. Clinical Nuclear Medicine, 2021, Publish Ahead of Print, ⟨10.1097/RLU.0000000000003691⟩. ⟨hal-04112073⟩
  • Anne-Laure Giraudet, David Kryza, Michael Hofman, Aurélie Moreau, Karim Fizazi, et al.. PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?. Therapeutic Advances in Medical Oncology, 2021, 13, pp.175883592110538. ⟨10.1177/17588359211053898⟩. ⟨hal-04112064⟩
  • Aurélie Moreau, Edouard Marie, Alice Bonneville-Levard, Alexandre Basle, David Kryza. Skull vault hemangioma mimicking neoplastic lesion on [68Ga]Ga-PSMA-11 PET/CT in a patient with glioblastoma: A case report. Radiology Case Reports, 2020, 15 (12), pp.2598-2601. ⟨10.1016/j.radcr.2020.10.005⟩. ⟨hal-04112088⟩
  • Jérémy Reverchon, Fouzi Khayi, Marianne Roger, Aurélie Moreau, David Kryza. Optimization of the radiosynthesis of [68Ga]Ga-PSMA-11 using a Trasis MiniAiO synthesizer: do we need to heat and purify?. Nuclear Medicine Communications, 2020, 41 (9), pp.977-985. ⟨10.1097/MNM.0000000000001233⟩. ⟨hal-04112090⟩
  • David Kryza, Frédéric Debordeaux, Laurent Azéma, Aref Hassan, Olivier Paurelle, et al.. Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas. PLoS ONE, 2020, 11 (2), pp.e0149387. ⟨10.1371/journal.pone.0149387⟩. ⟨hal-02139130⟩
  • Olga Kochebina, Adrien Halty, Jacqueline Taleb, David Kryza, Marc Janier, et al.. In vivo gadolinium nanoparticle quantification with SPECT/CT. EJNMMI Physics, 2019, 6 (1), ⟨10.1186/s40658-019-0246-y⟩. ⟨hal-02161585⟩
  • Aurélie Moreau, Olivia Febvey, Thomas Mognetti, Didier Frappaz, David Kryza. Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma. Frontiers in Oncology, 2019, 9, ⟨10.3389/fonc.2019.01134⟩. ⟨hal-02347683⟩
  • Aurélie Moreau, Anne Laure Giraudet, Thomas Mognetti, David Kryza. Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 2019, ⟨10.1007/s00259-019-04352-1⟩. ⟨hal-02139023⟩